Snowball logo
logo
MARK

Marksans Pharma Limited

223.00-3.40  (1.5%)
Start your journey to financial independence
Snowball will help you to track your portfolio, plan deposits to your brokerage account and increase passive income
Start

Frequently Asked Questions

What sector does Marksans Pharma Limited (MARKSANS) operate in?

Marksans Pharma Limited belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Marksans Pharma Limited (MARKSANS) current stock price?

As of the latest data, Marksans Pharma Limited stock price is ₹223.00, with a previous close of ₹226.40. Marksans Pharma Limited lost -₹3.40 in the last trading session, representing a -1.5% loss.

What is Marksans Pharma Limited (MARKSANS) current market capitalization?

Marksans Pharma Limited market cap is approximately 101.06 billion.

What is Marksans Pharma Limited (MARKSANS) Earnings Per Share (EPS)?

The trailing EPS is ₹8.14, and the forward EPS is ₹10.70.

What is Marksans Pharma Limited (MARKSANS) Price-to-Earnings (P/E) ratio?

Marksans Pharma Limited current P/E ratio is 27.4, with a forward P/E of 20.84.

What is Marksans Pharma Limited (MARKSANS) EBITDA?

Marksans Pharma Limited EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 1.67 billion.

Does Marksans Pharma Limited (MARKSANS) dividends?

Yes. Marksans Pharma Limited pays annual dividends with a forward yield of 0.27% and a forward payout of ₹0.60 per share.

When is the next ex-dividend date for Marksans Pharma Limited (MARKSANS)?

The next ex-dividend date is scheduled for September 17, 2025.

When is Marksans Pharma Limited (MARKSANS) next earnings report?

Marksans Pharma Limited is expected to release its next earnings report on June 30, 2025.

What is Marksans Pharma Limited (MARKSANS) beta (volatility) score?

Marksans Pharma Limited has a beta of 1.665, suggesting it is more volatile than the market.